MAPT and Alzheimer disease: In addition, these circular tau oligomersare found in non-AD brains, indicating a lower impact on neuronalpathology compared with PHFs, as previously hypothesized.56,65,66 This opening at the ends, consideringthe decreased analyzed distances of the filaments, could explain thedisruption of PHFs in the presence of the W-Tau peptide.